HCA Healthcare, Inc. $HCA Shares Sold by AE Wealth Management LLC

AE Wealth Management LLC lowered its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 56.0% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,548 shares of the company’s stock after selling 7,069 shares during the period. AE Wealth Management LLC’s holdings in HCA Healthcare were worth $2,126,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in HCA. Cheviot Value Management LLC bought a new stake in shares of HCA Healthcare in the 1st quarter worth about $26,000. Saudi Central Bank bought a new position in HCA Healthcare during the first quarter worth $26,000. WPG Advisers LLC acquired a new stake in shares of HCA Healthcare during the first quarter worth $27,000. Ameriflex Group Inc. acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at about $27,000. Finally, Chung Wu Investment Group LLC bought a new stake in shares of HCA Healthcare in the 2nd quarter worth approximately $27,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. This represents a 10.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Michael R. Mcalevey sold 3,892 shares of the company’s stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the transaction, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. This trade represents a 52.74% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Up 0.7%

Shares of NYSE HCA opened at $462.34 on Wednesday. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $478.88. The stock has a market capitalization of $105.50 billion, a price-to-earnings ratio of 17.87, a PEG ratio of 1.38 and a beta of 1.41. The stock’s fifty day simple moving average is $429.96 and its 200 day simple moving average is $393.98.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. The firm had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.HCA Healthcare’s revenue was up 9.6% on a year-over-year basis. During the same quarter last year, the business posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s payout ratio is currently 11.13%.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the stock. TD Cowen boosted their price target on shares of HCA Healthcare from $380.00 to $490.00 and gave the company a “buy” rating in a report on Monday, October 27th. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research note on Monday, October 27th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of HCA Healthcare in a report on Wednesday, October 8th. Morgan Stanley set a $425.00 target price on HCA Healthcare in a research report on Monday, October 27th. Finally, Wells Fargo & Company increased their price target on HCA Healthcare from $375.00 to $412.00 and gave the stock an “equal weight” rating in a research note on Tuesday, October 7th. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and ten have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $473.53.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.